Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.49 |
| ▸ | SNCA | P37840 | 3/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | MMP2 | P08253 | 4/20 | 0.48 |
| ▸ | MMP9 | P14780 | 4/20 | 0.48 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.48 |
| ▸ | PRKCG | P05129 | 1/20 | 0.48 |
| ▸ | PRKCB | P05771 | 1/20 | 0.48 |
| ▸ | PRKCA | P17252 | 1/20 | 0.48 |
| ▸ | PRKCH | P24723 | 1/20 | 0.48 |
| ▸ | PRKCI | P41743 | 1/20 | 0.48 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.48 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.48 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.48 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.48 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | BACE1 | P56817 | 4/20 | 0.47 |
| ▸ | GAA | P10253 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6841020 | 1.00 | HSD17B10 (0.49) | HSD17B10SNCAALOX15CYP1A2MMP2 | |
| SCHEMBL7413524 | 0.84 | KDM4E (0.41) | HSD17B10SNCAALOX15CYP1A2MMP2 | |
| SCHEMBL7412977 | 0.80 | SNCA (0.39) | HSD17B10SNCAALOX15CYP1A2MMP2 | |
| SCHEMBL7413000 | 0.80 | SNCA (0.39) | HSD17B10SNCAALOX15CYP1A2MMP2 | |
| Leucocianidol SCHEMBL31626217 | 0.79 | XDH (0.74) | HSD17B10SNCAALOX15CYP1A2MMP2 | |
| Leucocianidol SCHEMBL14339444 | 0.79 | XDH (0.74) | HSD17B10SNCAALOX15CYP1A2MMP2 | |
| Leucocianidol SCHEMBL29531793 | 0.79 | XDH (0.74) | HSD17B10SNCAALOX15CYP1A2MMP2 | |
| Leucocianidol SCHEMBL2298829 | 0.79 | XDH (0.74) | HSD17B10SNCAALOX15CYP1A2MMP2 | |
| Leucocianidol SCHEMBL1649595 | 0.79 | XDH (0.74) | HSD17B10SNCAALOX15CYP1A2MMP2 | |
| Leucocianidol SCHEMBL285598 | 0.79 | XDH (0.74) | HSD17B10SNCAALOX15CYP1A2MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040260076-A1 | Isolation, purification and synthesis of procyanidin B2 and uses thereof | PROTAMED, INC. | 2004-12-23 | — | — | US | claimed |
| US-20040260076-A1 | Isolation, purification and synthesis of procyanidin B2 and uses thereof | PROTAMED, INC. | 2004-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040260076-A1 | Isolation, purification and synthesis of procyanidin B2 and uses thereof | PSEN2, C9, AMY2A | HSD17B10 3120/4885SNCA 8/4885ALOX15 1937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.